IRCT2014121620341N1已完成未知
The effect of clarithromycin in preventing ventilator associated pneumonia
Shahid Sadoughi University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •ICU admission
- •Exclusion criteria: Neutropenia (Absolute Neutrophil Count less than 500 cells/µl); HIV infection; second or three degree atrioventricular (AV) block; Receiving oral corticosteroids in the past month
排除标准
- 未提供
研究者
相似试验
Unknown
3 期
Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma HominisBronchopulmonary DysplasiaNCT01652118Zekai Tahir Burak Women's Health Research and Education Hospital250
已完成
4 期
Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature InfantsChronic Lung DiseaseNCT01326611Zekai Tahir Burak Women's Health Research and Education Hospital273
招募中
不适用
inezolid and clarithromycin drug-interaction study in multidrug-resistant and extensively drug-resistant tuberculosis patients.-'drug interaction'- linezolid- clarithromycin- multidrug-resistant and extensively drug-resistant tuberculosis (MDR/XDR-TB)in dutch/ in het nederlands:- geneesmiddelinteractie- linezolid- claritromycine- multidrug-resistente and extensieve drug-resistente tuberculose (MDR/XDR-TBC)NL-OMON24566niversity Medical Center GroningenA.t.t.n. Prof Dr JGW Kosterink, Department of Hospital and Clinical PharmacyP.O. Box 30.001; 9700 RB Groningen,The NetherlandsTel: +31 50 361 4071Fax: +31 50 361 4087Email: j.g.w.kosterink@umcg.nl7
已完成
Unknown
Therapeutic Effects of Clarithromycin and Molnupiravir in Management of COVID-19 PatientsJPRN-UMIN000048841Daido Central Hospital119
已完成
不适用
The pharmacokinetic effect of clarithromycin on the AUC0-12h of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patientstuberculosis10028440TBNL-OMON35904niversitair Medisch Centrum Groningen7